Be Part of the Next Wave in Robotic Biomanufacturing!
Multiply Labs is at the forefront of revolutionizing the field of robotics with a commitment to addressing a critical challenge in contemporary medicine: the efficient production of vital advanced biologics, including cell therapies, gene therapies, mRNA therapies, and beyond.
Traditionally, the creation of advanced biological therapies involves labor-intensive and costly manual processes, often resulting in expenses that can soar to $0.5M-$2M per patient, limiting accessibility for many patients in need.
As the demand for scientific expertise grows against a backdrop of heightened product complexity and ever-increasing costs, the integration of robotics and AI offers a promising solution, making the automated production of biologics not only feasible but also reliable and economically viable.
We envision a future where biomanufacturing facilities are fully automated, closed-loop systems that are scalable, thereby making essential therapies widely available to patients who need them most.
The Importance of Our Work
At Multiply Labs, we don’t just create robots; we are building the essential infrastructure for the next generation of biologics manufacturing. Our innovative technology empowers biopharmaceutical companies to ramp up production without needing to modify their scientific approaches, significantly lowering regulatory obstacles and reducing costs to a level where these crucial treatments can effectively reach patients.
Our Vision & Technology
Our Mission: To develop the world’s most advanced robotic systems that ensure life-saving therapies are accessible to everyone.
Our Technology: Cutting-edge robotic orchestration, high-precision automation, cloud-integrated hardware-software solutions, dextrous manipulation techniques, and advanced imitation learning.
Our Location: Based in the vibrant city of San Francisco, CA.
Our Support: Backed by leading investors such as Casdin Capital, Lux Capital, and Y Combinator.